Structural Characterisation of TetR/AcrR Regulators in Streptomyces fildesensis So13.3: An In Silico CRISPR-Based Strategy to Influence the Suppression of Actinomycin D Production
- PMID: 40429982
- PMCID: PMC12112392
- DOI: 10.3390/ijms26104839
Structural Characterisation of TetR/AcrR Regulators in Streptomyces fildesensis So13.3: An In Silico CRISPR-Based Strategy to Influence the Suppression of Actinomycin D Production
Abstract
The growing threat of antimicrobial resistance has intensified the search for new bioactive compounds, particularly in extreme environments such as Antarctica. Streptomyces fildesensis So13.3, isolated from Antarctic soil, harbours a biosynthetic gene cluster (BGC) associated with actinomycin D production, an antibiotic with biomedical relevance. This study investigates the regulatory role of TetR/AcrR transcription factors encoded within this biosynthetic gene cluster (BGC), focusing on their structural features and expression under different nutritional conditions. Additionally, we propose that repressing an active pathway could lead to the activation of silent biosynthetic routes, and our in-silico analysis provides a foundation for selecting key mutations and experimentally validating this strategy. Expression analysis revealed that TetR-279, in particular, was upregulated in ISP4 and IMA media, suggesting its participation in nutrient-dependent BGC regulation. Structural modelling identified key differences between TetR-206 and TetR-279, with the latter containing a tetracycline-repressor-like domain. Molecular dynamics simulations confirmed TetR-279's structural stability but showed that the S166P CRISPy-web-guided mutation considerably affected its flexibility, while V167A and V167I had modest effects. These results underscore the importance of integrating omics, structural prediction, and gene editing to evaluate and manipulate transcriptional regulation in non-model bacteria. Targeted disruption of TetR-279 may derepress actinomycin biosynthesis, enabling access to silent or cryptic secondary metabolites with potential pharmaceutical applications.
Keywords: Antarctic Streptomyces; CRISPR-based activation; biosynthetic gene clusters; molecular dynamics simulation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
TetR-Type Regulator SLCG_2919 Is a Negative Regulator of Lincomycin Biosynthesis in Streptomyces lincolnensis.Appl Environ Microbiol. 2018 Dec 13;85(1):e02091-18. doi: 10.1128/AEM.02091-18. Print 2019 Jan 1. Appl Environ Microbiol. 2018. PMID: 30341075 Free PMC article.
-
TetR family regulator AbrT controls lincomycin production and morphological development in Streptomyces lincolnensis.Microb Cell Fact. 2024 Aug 8;23(1):223. doi: 10.1186/s12934-024-02498-8. Microb Cell Fact. 2024. PMID: 39118116 Free PMC article.
-
Disruption of a methyltransferase gene in actinomycin G gene cluster in Streptomyces iakyrus increases the production of phenazinomycin.FEMS Microbiol Lett. 2014 Mar;352(1):62-8. doi: 10.1111/1574-6968.12370. Epub 2014 Jan 27. FEMS Microbiol Lett. 2014. PMID: 24383524
-
TetR and OmpR family regulators in natural product biosynthesis and resistance.Proteins. 2025 Jan;93(1):38-71. doi: 10.1002/prot.26621. Epub 2023 Oct 24. Proteins. 2025. PMID: 37874037 Review.
-
The tylosin-biosynthetic genes of Streptomyces fradiae.Antonie Van Leeuwenhoek. 2001 Sep;79(3-4):229-34. doi: 10.1023/a:1012065300116. Antonie Van Leeuwenhoek. 2001. PMID: 11816964 Review.
References
-
- Núñez-Montero K., Barrientos L. Advances in Antarctic Research for Antimicrobial Discovery: A Comprehensive Narrative Review of Bacteria from Antarctic Environments as Potential Sources of Novel Antibiotic Compounds Against Human Pathogens and Microorganisms of Industrial Importance. Antibiotics. 2018;7:90. doi: 10.3390/antibiotics7040090. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources